Melissa Manno
Ufficiale delle Risorse Umane presso KINIKSA PHARMACEUTICALS, LTD.
Posizioni attive di Melissa Manno
Società | Posizione | Inizio | Fine |
---|---|---|---|
KINIKSA PHARMACEUTICALS, LTD. | Ufficiale delle Risorse Umane | 01/06/2018 | - |
Storia della carriera di Melissa Manno
Precedenti posizioni note di Melissa Manno
Società | Posizione | Inizio | Fine |
---|---|---|---|
ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/06/2015 | 01/05/2017 |
SYNAGEVA BIOPHARMA CORP | Ufficiale delle Risorse Umane | 01/01/2014 | 01/06/2015 |
Formazione di Melissa Manno
Keene State College | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 5 |
Posizioni
Human Resources Officer | 2 |
Undergraduate Degree | 1 |
Corporate Officer/Principal | 1 |
Settori
Health Technology | 4 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
KINIKSA PHARMACEUTICALS, LTD. | Health Technology |
Aziende private | 2 |
---|---|
Synageva BioPharma Corp.
Synageva BioPharma Corp. BiotechnologyHealth Technology Synageva BioPharma Corp. is a biopharmaceutical company which focuses on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and high unmet medical need. The company is currently evaluating sebelipase alfa in global clinical trials for LAL Deficiency, a lysosomal storage disease associated with liver damage and accelerated atherosclerosis in children and adults, and in infants, premature death often before six months of age. Synageva BioPharma was founded in 1993 and is headquartered in Lexington, MA. | Health Technology |
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- Melissa Manno
- Esperienza